Etienne Régulier - Concepedia

Concepedia

Author

Etienne Régulier

École Polytechnique Fédérale de Lausanne

Also Known As

E Regulier, E Régulier, E. Regulier, E. Régulier, Etienne Regulier, Etienne Régulier, Regulier, E.

41

Publications

2.4K

Citations

23

H-Index

70

Concepts

All Affiliations

École Polytechnique Fédérale de Lausanne Commissariat à l'Énergie Atomique et aux Énergies Alternatives Centre National de la Recherche Scientifique Transgene (France)Institut d'Imagerie Biomédicale

ER

About

Etienne Régulier is an author at École Polytechnique Fédérale de Lausanne specializing in medicine, cell biology, and neurodegenerative diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	1.4K
2	Engineering	3	3	430
3	Natural Sciences	2	2	305
4	Social Sciences	2	2	117
5	Biochemistry	1	1	110

Etienne Régulier

×

25

Publications

2.4K

Citations

23

H-Index

	Year	Citations
In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. Philippe Erbs, Etienne Régulier, Jacqueline Kintz, PubMed EngineeringApoptosisCell DeathGene DeliveryAdenovirus-mediated Transfer	2000	208
Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease Christophe Lo Bianco, James Shorter, Etienne Régulier, Journal of Clinical Investigation Molecular BiologySynaptic SignalingRat ModelAlzheimer's DiseaseAutophagy	2008	195
Akt is altered in an animal model of Huntington's disease and in patients Emilie Colin, Etienne Régulier, Valérie Perrin, European Journal of Neuroscience	2005	159
Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood Heike Runne, Alexandre Kuhn, Edward J. Wild, Proceedings of the National Academy of Sciences EngineeringGeneticsPeripheral BloodTranscriptomics TechnologyNeurochemical Biomarkers	2007	140
Neuroprotection by Hsp104 and Hsp27 in Lentiviral-based Rat Models of Huntington's Disease Valérie Perrin, Etienne Régulier, Toufik Abbas‐Terki, Molecular Therapy	2007	136
Inhibition of Calcineurin by FK506 Protects against Polyglutamine-Huntingtin Toxicity through an Increase of Huntingtin Phosphorylation at S421 Raúl Pardo, Emilie Colin, Etienne Régulier, Journal of Neuroscience	2006	134
Single-step detection of mutant huntingtin in animal and human tissues: A bioassay for Huntington’s disease Andreas Weiss, Dorothée Abramowski, Miriam Bibel, Analytical Biochemistry Knockout MouseNeurodegenerative DiseasesHuntington ’Molecular Biological MethodMedicine	2009	127
Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington’s disease Andreas Weiss, Corinna Klein, Ben Woodman, Journal of Neurochemistry	2007	112
MAP Kinase Phosphatase 1 (MKP-1/DUSP1) Is Neuroprotective in Huntington's Disease via Additive Effects of JNK and p38 Inhibition David Taylor, Roger Moser, Etienne Régulier, Journal of Neuroscience	2013	111
Dose-Dependent Neuroprotective Effect of Ciliary Neurotrophic Factor Delivered via Tetracycline-Regulated Lentiviral Vectors in the Quinolinic Acid Rat Model of Huntington's Disease Etienne Régulier, Luís Pereira de Almeida, Birgit Sommer, Human Gene Therapy ImmunologyNeuroinflammationExperimental NeuropathologyNeurologyEnzyme-linked Immunosorbent Assay	2002	110

Page 1